APA (7th ed.) Citation

D, R. (2023). Continuous glucose monitoring metrics (Mean Glucose, time above range and time in range) are superior to glycated haemoglobin for assessment of therapeutic efficacy. Diabetes, obesity & metabolism, 25(2), 596. https://doi.org/10.1111/dom.14906

Chicago Style (17th ed.) Citation

D, Rodbard. "Continuous Glucose Monitoring Metrics (Mean Glucose, Time Above Range and Time in Range) Are Superior to Glycated Haemoglobin for Assessment of Therapeutic Efficacy." Diabetes, Obesity & Metabolism 25, no. 2 (2023): 596. https://doi.org/10.1111/dom.14906.

MLA (9th ed.) Citation

D, Rodbard. "Continuous Glucose Monitoring Metrics (Mean Glucose, Time Above Range and Time in Range) Are Superior to Glycated Haemoglobin for Assessment of Therapeutic Efficacy." Diabetes, Obesity & Metabolism, vol. 25, no. 2, 2023, p. 596, https://doi.org/10.1111/dom.14906.